Mark Pruzanski
2012
In 2012, Mark Pruzanski earned a total compensation of $3.3M as Chief Executive Officer and President at Intercept Pharmaceuticals, a 299% increase compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Non-Equity Incentive Plan | $212,063 |
| Option Awards | $924,996 |
| Salary | $377,000 |
| Stock Awards | $1,674,506 |
| Other | $2,373 |
| Total | $3,310,938 |
Pruzanski received $1.7M in stock awards, accounting for 51% of the total pay in 2012.
Pruzanski also received $120K in bonus, $212.1K in non-equity incentive plan, $925K in option awards, $377K in salary and $2.4K in other compensation.
Rankings
In 2012, Mark Pruzanski's compensation ranked 2,071st out of 11,487 executives tracked by ExecPay. In other words, Pruzanski earned more than 82.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,071 out of 11,487 | 82nd |
Division Manufacturing | 728 out of 4,253 | 83rd |
Major group Chemicals And Allied Products | 163 out of 1,203 | 87th |
Industry group Drugs | 94 out of 925 | 90th |
Industry Pharmaceutical Preparations | 78 out of 700 | 89th |
Source: SEC filing on April 12, 2013.
Pruzanski's colleagues
We found two more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2012.